Relative	relative	O	O	O	O
efficacy	efficacy	O	O	O	O
and	and	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
of	of	O	O	O	O
netilmicin	netilmicin	O	O	OTHERS	I
and	and	O	O	O	O
tobramycin	tobramycin	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
oncology	oncology	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
prospectively	prospectively	O	O	O	O
compared	compared	O	O	O	O
the	the	O	O	O	O
efficacy	efficacy	O	O	O	O
and	and	O	O	O	O
safety	safety	O	O	O	O
of	of	O	O	O	O
netilmicin	netilmicin	O	O	OTHERS	I
sulfate	sulfate	O	O	OTHERS	I
or	or	O	O	O	O
tobramycin	tobramycin	CHEMICALS	O	OTHERS	I
sulfate	sulfate	O	O	OTHERS	I
in	in	O	O	O	O
conjunction	conjunction	O	O	O	O
with	with	O	O	O	O
piperacillin	piperacillin	O	O	OTHERS	I
sodium	sodium	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
118	118	O	O	O	O
immunocompromised	immunocompromised	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
presumed	presumed	O	O	O	O
severe	severe	O	O	O	O
infections	infections	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
two	two	O	O	O	O
treatment	treatment	O	O	O	O
regimens	regimens	O	O	O	O
were	were	O	O	O	O
equally	equally	O	O	O	O
efficacious	efficacious	O	O	O	O
.	.	O	O	O	O

Nephrotoxicity	nephrotoxicity	O	DISEASE	OTHERS	I
occurred	occurred	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
similar	similar	O	O	O	O
proportion	proportion	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
treated	treated	O	O	O	O
with	with	O	O	O	O
netilmicin	netilmicin	O	O	OTHERS	I
and	and	O	O	O	O
tobramycin	tobramycin	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
17	17	O	O	O	O
%	%	O	O	O	O
vs	vs	O	O	O	O
11	11	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Ototoxicity	ototoxicity	O	DISEASE	OTHERS	I
occurred	occurred	O	O	O	O
in	in	O	O	O	O
four	four	O	O	O	O
(	(	O	O	O	O
9.5	9.5	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
of	of	O	O	O	O
42	42	O	O	O	O
netilmicin	netilmicin	O	O	OTHERS	I
and	and	O	O	O	O
piperacillin	piperacillin	O	O	OTHERS	I
and	and	O	O	O	O
in	in	O	O	O	O
12	12	O	O	O	O
(	(	O	O	O	O
22	22	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
of	of	O	O	O	O
54	54	O	O	O	O
tobramycin	tobramycin	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
piperacillin-treated	piperacillin-treated	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

Of	of	O	O	O	O
those	those	O	O	O	O
evaluated	evaluated	O	O	O	O
with	with	O	O	O	O
posttherapy	posttherapy	O	O	O	O
audiograms	audiograms	O	O	O	O
,	,	O	O	O	O
three	three	O	O	O	O
of	of	O	O	O	O
four	four	O	O	O	O
netilmicin	netilmicin	O	O	OTHERS	I
and	and	O	O	O	O
piperacillin-treated	piperacillin-treated	O	O	O	O
patients	patients	O	O	O	O
had	had	O	O	O	O
auditory	auditory	O	O	O	O
thresholds	thresholds	O	O	O	O
return	return	O	O	O	O
to	to	O	O	O	O
baseline	baseline	O	O	O	O
compared	compared	O	O	O	O
with	with	O	O	O	O
one	one	O	O	O	O
of	of	O	O	O	O
nine	nine	O	O	O	O
tobramycin	tobramycin	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
piperacillin-treated	piperacillin-treated	O	O	O	O
patients	patients	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
greater	greater	O	O	O	O
than	than	O	O	O	O
or	or	O	O	O	O
equal	equal	O	O	O	O
to	to	O	O	O	O
15-dB	15-db	O	O	O	O
increases	increases	O	O	O	O
in	in	O	O	O	O
auditory	auditory	O	O	O	O
threshold	threshold	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
proportion	proportion	O	O	O	O
of	of	O	O	O	O
total	total	O	O	O	O
greater	greater	O	O	O	O
than	than	O	O	O	O
or	or	O	O	O	O
equal	equal	O	O	O	O
to	to	O	O	O	O
15-dB	15-db	O	O	O	O
changes	changes	O	O	O	O
(	(	O	O	O	O
increases	increases	O	O	O	O
and	and	O	O	O	O
decreases	decreases	O	O	O	O
)	)	O	O	O	O
was	was	O	O	O	O
significantly	significantly	O	O	O	O
lower	lower	O	O	O	O
in	in	O	O	O	O
netilmicin	netilmicin	O	O	OTHERS	I
and	and	O	O	O	O
piperacillin-	piperacillin-	O	O	O	O
vs	vs	O	O	O	O
tobramycin	tobramycin	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
piperacillin-treated	piperacillin-treated	O	O	O	O
patients	patients	O	O	O	O
(	(	O	O	O	O
18	18	O	O	O	O
of	of	O	O	O	O
78	78	O	O	O	O
vs	vs	O	O	O	O
67	67	O	O	O	O
of	of	O	O	O	O
115	115	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
conclude	conclude	O	O	O	O
that	that	O	O	O	O
aminoglycoside-associated	aminoglycoside-associated	O	O	O	O
ototoxicity	ototoxicity	O	DISEASE	OTHERS	I
was	was	O	O	O	O
less	less	O	O	O	O
severe	severe	O	O	O	O
and	and	O	O	O	O
more	more	O	O	O	O
often	often	O	O	O	O
reversible	reversible	O	O	O	O
with	with	O	O	O	O
netilmicin	netilmicin	O	O	OTHERS	I
than	than	O	O	O	O
with	with	O	O	O	O
tobramycin	tobramycin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

